Ophthalmic compositions containing a nitric oxide releasing prostamide
US10688073B2 · kind B2 · utility
3Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2019 |
| Grant date | Jun 23, 2020 |
| Priority date | — |
| Expiry date | Jul 10, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides aqueous ophthalmic compositions in the form of solution comprising hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and macrogol 15 hydroxystearate as the only solubilizing agent, and a method for their preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.